[Minimal residual disease before post-remission therapy predicts outcomes in younger adult with intermediate-risk acute myeloid leukemia]
Zhonghua Xue Ye Xue Za Zhi
.
2019 Feb 14;40(2):147-151.
doi: 10.3760/cma.j.issn.0253-2727.2019.02.011.
[Article in Chinese]
Authors
Y Zhang
1
,
Y M Zhang
,
Q Chen
,
G S Tang
,
H Y Qiu
,
L Gao
,
J Chen
,
X Ni
,
L Chen
,
W P Zhang
,
J M Yang
,
J M Wang
,
X X Hu
Affiliation
1
Department of Hematology, Changhai Hospital, the Second Military Medical University; Institute of Hematologic Disease of Chinese PLA, Shanghai 200433, China.
PMID:
30831632
PMCID:
PMC7342654
DOI:
10.3760/cma.j.issn.0253-2727.2019.02.011
No abstract available
Grants and funding
基金项目：国家自然科学基金面上项目（81770160、81470321、81270567、81530047）；上海市卫生计生委卫生系统优秀学科带头人培养计划（2017BR012）